CURRENT STATUS OF CONDUCTING FUNCTION TESTS IN REPEATED DOSE TOXICITY STUDIES IN JAPAN
スポンサーリンク
概要
- 論文の詳細を見る
It seems desirable to conduct as many function tests as possible in repeated dose toxicity studies, but is it practicable? The current status of conducting function tests in repeated dose toxicity studies in Japan was investigated by a literature survey of more than one thousand papers published in seven Japanese toxicology journals during the past 10 years and by a questionnaire survey directed to toxicologists among the Japan Pharmaceutical Manufacturers Association (JPMA) member companies. The function tests often carried out in repeated dose toxicity studies were, for example: 1) electro-retinography (ERG) and visually evoked potential (VEP) for visual test and tonometer for intraocular pressure; 2) auricular reflex, evoked response audiometry (ERA) and auditory bfainstem response (ABR) to sound stimuli; 3) respiration and heart rate, electrocardiogram (ECG) and blood pressure by noninvasive cuff methods or using electronic devices such as telemetry; 4) body temperature, spontaneous motility and some adaptation tests (using rotarod and sloped plate in rats); 5) indocyanin (ICG) or bromosul-fophtalein (BSP) for hepatic test; 6) phenolsulfonphtalein (PSP) and creatinine clearance for renal test; and 7) immunoglobulin, leukocyte phagocytosis, lymphocyte blastgenesis and natural killer cell (NK) for immuno-reaction test. Limitations to conducting function tests in repeated dose toxicity studies and issues to be resolved were discussed, based on questions and suggestions given by the respondents to the questionnaire. Although it certainly seemed desirable to conduct as many function tests as possible in repeated dose toxicity studies, most of the function tests so far introduced into toxicity studies were not satisfactory, because those tests could not be carried out under the restricted conditions of repeated dose toxicity studies, and not much reliable data from function tests were obtainable. A variety of function tests should firstly be incorporated into single dose toxicity studies together with development of a new concept for methodology in safety pharmacology.
- 日本トキシコロジー学会の論文
- 1997-12-15
著者
-
Hashimoto Masaharu
ファイザー製薬
-
Yoshida M
Kansai Medical Univ. Osaka Jpn
-
Hashimoto Masaharu
Fujisawa Pharmaceutical Co. Ltd.
-
Matsuzawa Toshiaki
Yamanouchi Pharm.Co., Ltd.
-
Tamura S
Mitsubishi Chemical Corp.
-
Yoshida M
Department Of Pathology Sasaki Institute
-
NARA Hiroshi
Shionogi & Co., Ltd.
-
YOSHIDA Masaru
Nippon Shinyaku Co., Ltd.
-
TAMURA Shigeru
Mitsubishi Chemical Corp.
-
IGARASHI Toshiji
Eisai Co., Ltd.
-
Nara H
Shionogi & Co. Ltd. Osaka Jpn
-
Matsuzawa Toshiaki
Yamanouchi Pharmaceutical Co. Ltd.
-
Igarashi Toshiji
Eisai Co. Ltd.
関連論文
- Time course of food consumption of mice in dietary administration.
- Study for adrenal medullary hyperplasia induced by lactitol in male SD rats.
- Sample surveillance for clinical pathology testing.
- SEQUENTIAL ALTERATIONS IN CLINICAL BIOCHEMICAL INDICATORS OF RENAL FUNCTION IN 5/6 NEPHRECTOMIZED RATS : BASIC STUDY FOR RENAL TOXICITY USING 5/6 NEPHRECTOMIZED RATS
- Effect of low-dose puromycin on renal function in 5/6 nephrectomized rats
- Renal Toxicity Study Using Five Sixth-nephrectomized Rats : I Changes in toxicity of nephrotoxic substance by treatment-stages after nephrectomy
- Sample surveillance for clinical pathology testing(2) Analysis of blood chemical data
- BLOOD OF RATS AND DOGS FOR USE AS SURVEILLANCE SAMPLES : INVESTIGATION OF STORAGE AND TRANSPORTATION CONDITIONS
- CURRENT STATUS OF CONDUCTING FUNCTION TESTS IN REPEATED DOSE TOXICITY STUDIES IN JAPAN
- THE MECHANISM OF LACTITOL (NS-4) IN INDUCING ADRENOMEDULLARY PROLIFERATIVE LESION IN RATS
- ELECTRORETINOGRAPHIC CHANGES INDUCED BY ORGANOPHOSPHORUS PESTICIDES IN RATS
- EVALUATION OF THE NEPHROTOXICITY OF AROMATIC NITRO-AMINO COMPOUNDS BY URINARY ENZYME ACTIVITIES
- EFFECT OF INGESTION OF 6-PROPYL-2-THIOURACIL ON BIOCHEMICAL INDICES OF SELENIUM STATUS IN RATS
- Ifosfamide-induced urinary bladder lesion and its inhibition
- OPENING REMARKS(PROGRESS IN THE INTERNATIONAL HARMONISATION OF TOXICOLOGICAL TESTS AND SUBJECTS TO BE CONSIDERED FOR ITS IMPLEMENTATION)
- RECENT PROGRESS OF THE INTERNATIONAL HARMONIZATION OF TOXICOLOCIGAL TESTING : IMPACT AND IMPLIMENTATION OF ICH GUIDELINES
- 233 IS 12-MONTH TREATMENT ESSENTIAL FOR THE LONG TERM TOXICITY STUDY ?
- B-29 JPMA Survey on Current Status of Preclinical Studies Prerequisite to Clinical Trials of New Drugs
- Technical Factors Affecting in vivo Toxicity Studies(PRESIDENT LECTURE)
- Greeting and Editorial Message on Proceedings of the 29th Annual Meeting
- A Greeting of the Host Nation(PUBLIC NIGHT SEMINAR : HOW THE SAFETY OF MEDICINES IS INSURED)